These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma. Abd El-Baky RM, Hetta HF, Koneru G, Ammar M, Shafik EA, Mohareb DA, Abbas El-Masry M, Ramadan HK, Abu Rahma MZ, Fawzy MA, Fathy M. Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406 [Abstract] [Full Text] [Related]
5. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Attallah AM, Omran D, Marie MS, Abdelrazek M, Salama A, El Essawey R, Mobarak L, Maklad S, Omar A. Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308 [Abstract] [Full Text] [Related]
11. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH. Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924 [Abstract] [Full Text] [Related]
12. Association between Genetic Polymorphisms in MicroRNAs 196a2 (rs11614913) and 34 b/c (rs4938723) and Risk of Hepatocellular Carcinoma in Egyptian Patients. Ibrahim AA, El-Feki MA, Gamal M, Doudar NA, Marey H, Abd El Ghany WM, Abdalla NH. Asian Pac J Cancer Prev; 2022 Apr 01; 23(4):1373-1377. PubMed ID: 35485699 [Abstract] [Full Text] [Related]
14. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population. Farokhizadeh Z, Dehbidi S, Geramizadeh B, Yaghobi R, Malekhosseini SA, Behmanesh M, Sanati MH, Afshari A, Moravej A, Karimi MH. Ann Lab Med; 2019 Jan 01; 39(1):58-66. PubMed ID: 30215231 [Abstract] [Full Text] [Related]
17. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients. Elsayed HM, Nabiel Y, Sheta T. Immunol Invest; 2017 Feb 01; 46(2):123-133. PubMed ID: 27819525 [Abstract] [Full Text] [Related]
18. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. Han Y, Pu R, Han X, Zhao J, Zhang Y, Zhang Q, Yin J, Xie J, Shen Q, Deng Y, Ding Y, Li W, Li J, Zhang H, Cao G. PLoS One; 2013 Feb 01; 8(3):e58564. PubMed ID: 23516510 [Abstract] [Full Text] [Related]
20. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis. Tian T, Wang M, Zhu W, Dai ZM, Lin S, Yang PT, Liu XH, Liu K, Zhu YY, Zheng Y, Liu M, Dai ZJ. Aging (Albany NY); 2017 Jan 31; 9(2):381-392. PubMed ID: 28148887 [Abstract] [Full Text] [Related] Page: [Next] [New Search]